102 Participants Needed

VR-Based Mobility Training for Low Vision

(VR-IOMS Trial)

Recruiting at 1 trial location
LL
EL
Overseen ByEllen L Bowman, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The human subject research is a randomized, controlled training trial that tests the effectiveness of three Virtual Reality-based Intelligent Orientation and Mobility Specialists (VR-IOMSs) in teaching orientation and mobility (O\&M) task skills to low vision patients. It will be conducted on two sites, University of Alabama at Birmingham (UAB) and Alabama Institute for Deaf and Blind (AIDB). The same protocol will be used on both sites. UAB will be the sIRB for the trial. Three O\&M tasks will be studied, timing to cross a signalized street using the near lane parallel traffic surge skill, timing to cross an uncontrolled street using the traffic gap judgment skill and learning outdoor numbering system. A VR-IOMS will be develop for each task. The training does not involve research subjects walking into street traffic. Low vision subjects who have difficulties with these O\&M tasks due to their impaired vision will be randomized into three groups, learning the task from a VR-IOMS (experimental group), from a human Certified Orientation \& Mobility Specialist (COMS) in real streets (active control group) and not learning the task but spending the same amount of time watching low vision education videos (placebo group). All subjects will be evaluated by COMSs in real streets around the two study sites before training (pre-training), within 3 days after the completion of training (post-training) and 3 months after the completion of training (follow up). Their ability to perform the O\&M tasks will be assess quantitatively using objective methods. COMSs who conduct these evaluations will be blinded for subject training assignment. The primary outcome measure is the training effect, the difference in task performance between the pre-training and post-training real street evaluations. The training effects of the 3 groups will be compared to determine the training effectiveness of the VR-IOMS relative to human COMS. Secondary outcome measures include the retainment of the training effect. Objective assessment of the VR-IOMS training process and trainee subjective evaluation of the VR-IOMS training will also be analyzed.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you are under aggressive treatment for ocular diseases, such as receiving VEGF injections, you may not be eligible to participate.

What data supports the effectiveness of the treatment VR-Based Mobility Training for Low Vision?

Research shows that orientation and mobility training helps people with low vision maintain their independence by teaching them new skills to navigate their environment. Additionally, head-mounted display technology, which is similar to virtual reality, has been found to improve mobility and orientation in people with low vision.12345

Is VR-based mobility training safe for people with low vision?

Research shows that virtual reality-based orientation and mobility training can improve street safety for people with low vision, and it appears to be as safe as real street training.12356

How is the VR-Based Mobility Training for Low Vision treatment different from other treatments?

This treatment uses virtual reality (VR) to create immersive environments that help people with low vision practice and improve their orientation and mobility skills, offering a more interactive and engaging experience compared to traditional methods.12357

Research Team

LL

Lei Liu, PhD

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

This trial is for individuals with low vision who have not had formal orientation and mobility (O&M) training, can hear normally or with correction, aim to improve O&M skills, and have stable late-onset visual impairment. They should be able to perform basic tasks like using a mouse or joystick and walking short distances. People with rapidly progressing eye diseases, aggressive treatments ongoing, congenital impairments, existing mastery of the skills being taught, difficulty speaking English, or a history of seizures/motion sickness cannot join.

Inclusion Criteria

You need to be able to use a computer mouse or a joystick.
My vision loss occurred later in life and has not changed recently.
I have not received formal orientation and mobility training.
See 6 more

Exclusion Criteria

Participants will be excluded from the training for the skills that they already master.
Patients with congenital visual impairment will be excluded.
I am receiving eye injections for a retinal disease.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Pre-training Evaluation

Participants are evaluated by COMSs in real streets to assess baseline O&M task performance

1 week
1 visit (in-person)

Training

Participants undergo training using VR-IOMS, human COMS, or watch educational videos

1 week
Multiple sessions (in-person or virtual)

Post-training Evaluation

Participants are evaluated by COMSs in real streets to assess O&M task performance after training

Within 3 days after training
1 visit (in-person)

Follow-up

Participants are monitored for retention of training effects and safety in O&M tasks

3 months
1 visit (in-person)

Treatment Details

Interventions

  • No Orientation and Mobility Training
  • Orientation and Mobility Training with COMS
  • Orientation and Mobility Training with VR-IOMSs
Trial Overview The study tests three methods for teaching O&M skills to those with low vision: learning from Virtual Reality-based Intelligent Orientation and Mobility Specialists (VR-IOMS), from human specialists in real streets (COMS), or watching educational videos as a control group. The effectiveness will be measured by comparing participants' abilities before and after training in real street evaluations.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Orientation and Mobility Training with VR-IOMSsExperimental Treatment1 Intervention
Low vision subjects with Orientation and Mobility (O\&M) difficulties learning O\&M skills from Virtual Reality-base Intelligent O\&M Specialists (VR-IOMSs). VR-IOMSs are intelligent, computer-controlled automatic O\&M skill training programs in virtual streets.
Group II: Orientation and Mobility Training with COMSActive Control1 Intervention
Low vision subjects with Orientation and Mobility (O\&M) difficulties learning O\&M skills from human Certified O\&M Specialists (COMS) in real streets
Group III: No Orientation and Mobility TrainingPlacebo Group1 Intervention
Low vision subjects with Orientation and Mobility (O\&M) difficulties watching low vision education videos and discuss low vision issues not related to O\&M with COMSs.

Orientation and Mobility Training with VR-IOMSs is already approved in United States for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as VR-IOMSs for:
  • Teaching orientation and mobility task skills to low vision patients

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Findings from Research

A new standardized orientation and mobility training protocol for individuals with low vision has been developed, incorporating both current practices and theoretical frameworks to enhance its effectiveness.
The training consists of two face-to-face sessions and a follow-up call, and is currently being evaluated for its acceptability and effectiveness in a randomized controlled trial.
Orientation and mobility training for adults with low vision: a new standardized approach.Zijlstra, GA., Ballemans, J., Kempen, GI.[2022]
The review identified only two small quasi-randomised trials assessing orientation and mobility (O&M) training for adults with low vision, which showed no significant difference in effectiveness, indicating a lack of strong evidence for the benefits of O&M training.
The studies highlighted the need for better-designed randomized controlled trials (RCTs) to evaluate different types of O&M training, as well as the importance of using standardized measurement tools to assess mobility performance and quality of life in individuals with low vision.
Orientation and mobility training for adults with low vision.Virgili, G., Rubin, G.[2021]
The review identified only two small studies on orientation and mobility (O&M) training for adults with low vision, which showed mixed results; one study found no benefit while the other indicated some improvement, suggesting variability in training effectiveness.
There is currently insufficient evidence to determine the best type of O&M training for individuals with low vision, highlighting the need for more rigorous randomized controlled trials and standardized measurement tools to assess mobility performance.
Orientation and mobility training for adults with low vision.Virgili, G., Rubin, G.[2020]

References

Orientation and mobility training for adults with low vision: a new standardized approach. [2022]
Orientation and mobility training for adults with low vision. [2021]
Orientation and mobility training for adults with low vision. [2020]
Ability of Head-Mounted Display Technology to Improve Mobility in People With Low Vision: A Systematic Review. [2021]
Orientation and mobility training for adults with low vision. [2018]
Individuals with severely impaired vision can learn useful orientation and mobility skills in virtual streets and can use them to improve real street safety. [2022]
Development of Immersive Virtual Reality Environment for Assessment of Functional Vision in people with Low Vision: A Pilot Study. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity